NEKTAR THERAPEUTICS
Biopharma developing innovative medicines for autoimmune and inflammatory conditions.
NKTR | NDAQ
Overview
Corporate Details
- ISIN(s):
- US6402681083
- LEI:
- Country:
- United States of America
- Address:
- 455 MISSION BAY BOULEVARD SOUTH, 94158 SAN FRANCISCO
- Website:
- https://www.nektar.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Nektar Therapeutics is a clinical-stage biopharmaceutical company that discovers and develops innovative medicines for autoimmune and inflammatory conditions. Founded in 1990, the company's research focuses on resolving immune imbalances and selectively modulating the immune system to address the underlying causes of disease. Nektar is advancing a pipeline of first-in-class, disease-modifying therapeutic candidates in areas of high unmet medical need. The company has a strong track record of successful global partnerships that have led to the development of numerous commercially approved medicines.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all NEKTAR THERAPEUTICS filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NEKTAR THERAPEUTICS
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NEKTAR THERAPEUTICS via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
